US Patent 7671180 Fibroblast growth factor-like polypeptides and variants thereof
Patent 7671180 was granted and assigned to Amgen on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+113 characters)
Article
Patent abstract
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) fusion polypedtides.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07671180 Fibroblast growth factor-like polypeptides and variants thereof US Patent 7671180 Fibroblast growth factor-like polypeptides and variants thereof
Infobox
Patent Number
0767118000
Patent Number
767118000
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076711800
Date of Patent
March 2, 2010
0Patent Application Number
117337690
Date Filed
April 11, 2007
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076711800
Date of Patent
March 2, 2010
0Patent Application Number
117337690
Date Filed
April 11, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07671180 Fibroblast growth factor-like polypeptides and variants thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07671180
Date of patent
March 2, 2010
Patent application number
11733769
Date Filed
April 11, 2007
Patent primary examiner
Find more entities like US Patent 7671180 Fibroblast growth factor-like polypeptides and variants thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
